Beyond the Elevator Pitch | Inside Start-up Stories | Part 6
What if we could make cutting-edge cell therapies accessible to all, regardless of financial status? ๐
CYTEA BIO is turning this vision into reality.
As HeadhunterAngels, we celebrate innovative biotech startups that are making a difference. Today, we’re excited to introduce CYTEA BIO, a Swiss-French biotech company based in Montpellier:
CYTEA BIO is addressing the urgent need for affordable and scalable cell therapies. Their groundbreaking ๐๐ข๐งโข ๐๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ enables the production of powerful antibody-cell conjugates, revolutionizing treatments for cancers and immune diseases.
Key innovations include:
๐งฌ Modular ๐๐ข๐งโข ๐๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ: creating flexible, powerful treatments for oncology and immunology.
๐งช Affordable solutions: reducing the costs of cell therapies, making them more accessible.
๐ High-efficacy treatments: enhancing patient outcomes with minimal side effects.
๐ Global impact: offering hope to patients worldwide, irrespective of wealth.
๐ Read the full interview with COO Marc CRITON and learn more about how CYTEA BIO is transforming the future of cell therapy!